Evidence map›Paper›PMID 38223660›Full record

ArticleChina CDC weekly2024

Diagnosis, Treatment, and Associated Factors Among Patients with HCV Infection - Jiangsu Province, China, 2004-2020.

Dandan Yang, Jing Lu, Zhi Zhang, Chuanwu Sun, Zhuping Xu, Yao Qi, XiaoXia Liu, Huan Ding, Feifei Chai, Zhengdong Zhang and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Dandan YangDepartment of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Jing LuDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Jiangsu Province, Nanjing City, Jiangsu Province, China.
Zhi ZhangDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Jiangsu Province, Nanjing City, Jiangsu Province, China.
Chuanwu SunDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Xuzhou, Xuzhou City, Jiangsu Province, China.
Zhuping XuDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Wuxi, Wuxi City, Jiangsu Province, China.
Yao QiDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Yancheng, Yancheng City, Jiangsu Province, China.
XiaoXia LiuDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Zhenjiang, Zhenjiang City, Jiangsu Province, China.
Huan DingDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Wuxi, Wuxi City, Jiangsu Province, China.
Feifei ChaiDepartment of Sexually Transmitted Diseases and AIDS, Center for Disease Control and Prevention of Xuzhou, Xuzhou City, Jiangsu Province, China.
Zhengdong ZhangDepartment of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Baoli ZhuDepartment of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Jiangsu Provincial Center for Disease Control and Prevention · CNLiu Zhou Center for Disease Prevention and Control · CNWuxi Taihu Hospital · CNAIDS United · USNanjing Medical University · CNXinjiang Uygur Autonomous Region Disease Prevention and Control Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known on this topic?: The global efforts to address the hepatitis C virus (HCV) are progressing, but there are still significant gaps in the diagnosis and treatment of HCV, leading to an increasing number of deaths related to HCV. What is added by this report?: An extensive investigation was conducted to assess HCV RNA diagnosis, treatment uptake, and associated factors among individuals infected with HCV within Jiangsu Province. The study encompassed a large geographical area and utilized a substantial sample size. What are the implications for public health practice?: Implementing focused interventions to improve the timely diagnosis of HCV RNA and increase the uptake of HCV treatment could effectively reduce the future burden of HCV-related health problems, deaths, and healthcare expenses. This is essential for achieving the global target of eliminating hepatitis C.

Indexed as

DiagnosisHCVRetrospective surveyTreatment

Identifiers

PMID38223660
PMCPMC10787339
OpenAlexW4390612408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.